Resources for Researchers
NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.
Aerobiology—Integrated Research Facility at Fort Detrick
The aerobiology section at the Integrated Research Facility at Fort Detrick (IRF‑Frederick) develops aerosol animal models of disease caused by high-consequence pathogens within animal biosafety level 4 (ABSL-4) containment laboratories.
Animal Models of Disease—Integrated Research Facility at Fort Detrick
Developing, characterizing, and refining animal models are key to advancing medical countermeasures for high-consequence pathogens.
BEI Resources Repository
The BEI Resources Repository is a central repository that supplies organisms and reagents to the broad community of microbiology and infectious diseases researchers. Materials are available through an online catalog.
Biocontainment Laboratory—Boston University National Emerging Infectious Diseases Laboratory
The National Emerging Infectious Diseases Laboratories (NEIDL) is one of two National Biocontainment Laboratories constructed under a grant from the National Institute of Allergy and Infectious Diseases.
Biocontainment Laboratory—University of Texas Medical Branch Galveston National Laboratory
As one of two National Biocontainment Laboratories constructed under grants awarded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the Galveston National Laboratory (GNL) enables progress in our understanding of the fundamental mechanisms u
Core Services—Integrated Research Facility at Fort Detrick
The core services group at the Integrated Research Facility at Fort Detrick (IRF‑Frederick) provides cell culture, hematology, hemostasis, clinical chemistry, microbiology, and molecular virology support for monitoring animals in infectious disease studies.
Drug Screening—Integrated Research Facility at Fort Detrick
The drug screening team at the Integrated Research Facility at Fort Detrick (IRF‑Frederick) can test and characterize the antiviral activity of novel compounds, drugs, and antibodies against multiple viruses in multiple cell lines under a variety of conditions.
Electron Microscopy (EM)—Integrated Research Facility at Fort Detrick
The electron microscopy laboratory at the Integrated Research Facility at Fort Detrick (IRF‑Frederick) has a variety of capabilities for the analysis of biological samples at an ultrastructural level.
Genomic Centers for Infectious Diseases (GCID) Resources
The GCID use and develop or improve innovative applications of genomic technologies, such as RNA sequencing and metagenomics, and provide rapid and cost-efficient production of high-quality genome sequences of microorganisms, invertebrate vectors of infectious diseases, and hosts and host microbiomes. Multiple strains and isolates of specific microbial species, populations and communities have been and continue to be sequenced.
Imaging Sciences—Integrated Research Facility at Fort Detrick
Diagnostic and molecular imaging are important components of research studies, as they provide real-time, longitudinal, structural, and functional insights into disease processes that cannot be obtained by other laboratory tests.
Immunology—Integrated Research Facility at Fort Detrick
The immunology laboratory at the Integrated Research Facility at Fort Detrick (IRF-Frederick) offers a variety of capabilities to interrogate the immune responses against pathogens requiring maximum containment.
In Vitro Assessment for Antimicrobial Activity Program
The In Vitro Assessment for Antimicrobial Activity program provides capability in a broad range of in vitro assessments to evaluate promising candidate countermeasures for antimicrobial activity against microbial pathogens and vectors, including those derived from clinical speci
International Clinical Sciences Support Center (ICSSC)
The ICSSC provides a wide range of support services to clinical investigators who are conducting international research funded by the Division of Microbiology and Infectious Diseases (DMID), including consultation and assistance to investigators for protocol development, site assessment, data man
Interventional Agent Development Services
The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins.
Note: Devices are excluded.
Orfeome
The Orfeome Project is part of the NIAID-supported Functional Genomics Program.
Outbreak Response—Integrated Research Facility at Fort Detrick
The primary objective of the response team is to develop and foster overseas relationships through the support of research studies and clinical trials.
Pathology and Histology—Integrated Research Facility at Fort Detrick
The pathology and histology laboratories at the Integrated Research Facility at Fort Detrick (IRF‑Frederick) work together to conduct comprehensive postmortem examinations on laboratory animals of a variety of species studied as models for high-consequence emerging human viral infections.
Phase I Clinical Trial Units for Therapeutics
The Phase I Clinical Trial Units for Therapeutics support the design, development, implementation, and conduct of Phase I clinical trials to assess safety, pharmacokinetics, and/or pharmacodynamics of licensed and investigational therapeutic products, including immunomodulatory agents and monoclo
Preclinical Models of Infectious Disease
This contract program supports the development and refinement of animal models and animal replacement technologies and provides in vivo preclinical testing services, ranging from screening and proof-of-concept to GLP efficacy studies.
Structural Genomics Centers for Infectious Diseases—Resources
The Structural Genomics Centers for Infectious Diseases provide the research community with: 3-D protein structures and protein-ligand complexes; Sequence-verified clones and peptides; Services that deliver requested 3-D structure determination; and Molecular screening of proteins in complex with inhibitors, cofactors and substrate analogs
Therapeutic Development Services
The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins.
Vaccine Development Services
The Vaccine Development Services program offers a collection of preclinical services to support the development of vaccines intended for use in the investigation, control, prevention, and treatment of a wide range of infectious agents (other than HIV).
Virology—Integrated Research Facility at Fort Detrick
The virology team at the Integrated Research Facility at Fort Detrick (IRF‑Frederick) has extensive expertise working with a range of high‑consequence viral pathogens.
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
The WRCEVA program maintains the Emerging Viruses and Arboviruses Reference Collection and provides reagents and support for investigations of virus outbreaks throughout the world.